Biotin-facilitated transport in gram negative bacteria

Details Biotin-facilitated transport in gram negative bacteria Biotin-facilitated transport in gram negative bacteria

2004-11-12

2009-10-13

Duffy, Patricia A (Department: 1645)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving viable micro-organism

C435S032000

Reexamination Certificate

active

07601511

ABSTRACT:
Biotinylation of compounds such as peptides and peptidomimetics facilitates illicit transport of the compounds into Gram negative bacteria.

REFERENCES:
patent: 5108921 (1992-04-01), Low et al.
patent: 5416016 (1995-05-01), Low et al.
patent: 5635382 (1997-06-01), Low et al.
patent: 5688488 (1997-11-01), Low et al.
patent: 5820847 (1998-10-01), Low et al.
patent: 5976535 (1999-11-01), Fritzberg et al.
patent: 6306993 (2001-10-01), Rothbard et al.
patent: 6322788 (2001-11-01), Kim
patent: 6451971 (2002-09-01), Akiyama et al.
patent: 6495663 (2002-12-01), Rothbard et al.
patent: 6624140 (2003-09-01), Abraham et al.
patent: 7033594 (2006-04-01), Low et al.
patent: 2002/0131965 (2002-09-01), Rothbard et al.
patent: 2003/0162719 (2003-08-01), Rothbard et al.
patent: 2004/0049011 (2004-03-01), Abraham et al.
patent: 2005/0136008 (2005-06-01), Elmaleh et al.
patent: 2006/0111274 (2006-05-01), Rothbard et al.
patent: 2 545 679 (2005-05-01), None
patent: 100 55 789 (2002-06-01), None
patent: 1 036 798 (2000-09-01), None
patent: 1 036 798 (2003-07-01), None
patent: 90/12096 (1990-10-01), None
patent: WO 90/12096 (1990-10-01), None
patent: WO 95/31556 (1995-11-01), None
patent: 98/52614 (1998-11-01), None
patent: WO 98/52614 (1998-11-01), None
patent: WO 98/52614 (1998-11-01), None
patent: WO 99/06440 (1999-02-01), None
patent: WO 02/40511 (2002-03-01), None
patent: WO 02/40511 (2002-03-01), None
patent: WO 2005/032598 (2005-04-01), None
patent: WO 2005/046730 (2005-05-01), None
patent: WO 2005/046730 (2005-05-01), None
American Type Culture Collection, “ATTC No. 9721,” organism:Pseudomonas aeruginosaMigula; designation: NRS 112 [online]; Manassas, VA [retrieved on Feb. 23, 2007]. Retrieved from the Internet: <http://www.atcc.org/common/catalog
umSearch
umResults.cfm?atccNum=9721&CFID=10430581&CFTOKEN=76dd390cc23da4a9-DB0128C2-92C7-CF98-64C2BC85A22D7B2D>; 2 pgs.
American Type Culture Collection, “ATTC No. 25923,” organism:Staphylococcus aureusRosenbach; designation: Seattle 1945 [online]; Manassas, VA [retrieved on Feb. 23, 2007]. Retrieved from the Internet: <http://www.atcc.org/common/catalog
umSearch
umResults.cfm?atccNum=25923&CFID=10430581&CFTOKEN=76dd390cc23da4a9-DB0128C2-92C7-CF98-64C2BC85A22D7B2D>; 4 pgs.
Fickel et al., “Transport of impermeant substances inE. coliby way of oligopeptide permease,”Nat. New Biol., 1973;241:161-163.
Hussey et al., “Efficient Delivery of Streptavidin to Mammalian Cells: Clathrin-Mediated Endocytosis Regulated by a Synthetic Ligand,”J. Am. Chem. Soc., 2002; 124:6265-6273;S1-S8.
Miller,Experiments in Molecular Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1972).
Miller et al., “The design, synthesis and study of siderophore-antibiotic conjugates,”Biol. Met., 1991; 4:62-69.
Morley et al., “Backbone-modified analogues of small peptides: transport and antibacterial activity,”Biochem. Soc. Trans., 1983; 11:798-800.
Payne, “Peptides and micro-organisms,”Adv. Microb. Physiol., 1976; 13:55-113.
Payne, “Transport and utilization of peptides by bacteria,” inMicroorganisms and Nitrogen Sources, 1980; Title page, publication page and pp. 211-256.
Payne et al., “Peptide transport by micro-organisms,”Adv. Microb. Physiol., 1994; 36:1-80.
Piffeteau et al., “Biotin transport by a biotin-deficient strain ofEscherichia coli,” Biochim. Biophys. Acta, 1982; 688:29-36.
Piffeteau et al., “Biotin uptake: influx, efflux, and countertransport inEscherichia coli,” Biochim. Biophys. Acta, 1985; 816:77-82.
Prakash et al., “Active transport of biotin inEscherichia coliK-12,”J. Bacteriol., 1974; 120(2):785-791.
Press et al., “A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts,”Blood, 2001; 98:2535-2543.
Schägger et al., “Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1-100 kDa,”Anal. Biochem., 1987; 166:368-379.
Scherrer et al., “Molecular sieving by theBacillus megateriumcell wall and protoplast,”J. Bacteriol., 1971; 107:718-735.
Song et al., “Enhanced neuroprotective effects fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain delivery vector,”J. Pharmacol. Exp. Ther., 2002;301(2):605-610.
Staskawicz et al., “Phaseolotoxin transport inEscherichia coliandSalmonella typhimuriumvia the oligopeptide permease,”J. Bacteriol., 1980; 142:474-479.
Walker, Jennifer Renee, “Improving the Stability of Bioactive Peptides Using Protein-Based Motifs,” Ph.D. Dissertation, University of Georgia Department of Microbiology. Cover date: Dec. 2002. Publically available Oct. 23, 2003.
Walker et al., “Using protein-based motifs to stabilize peptides,”J. Peptide Research, 2003; 62:214-226.
Walker et al., “Biotinylation facilitates the uptake of large peptides byEscherichia coliand other Gram-negative bacteria,”Applied and Environmental Microbiology, 2005; 71(4):1850-1855.
Wittmann et al., “New synthetic siderophores and their β-lactam conjugates based on diamino acids and dipeptides,”Bioorg. Med. Chem., 2002; 10:1659-1670.
International Search Report and the Written Opinion of the Internation Searching Authority, dated Jul. 3, 2006. 22 pages.
International Preliminary Report on Patentability, dated Aug. 24, 2006. 13 pages.
Altman et al., “S Gene Product: Identification and Membrane Localization of a Lysis Control Protein,”J. Bacteriol., Sep. 1983; 155(3):1130-1137.
Ames et al., “Illicit Transport: The Oligopeptide Permease,”Proc. Natl. Acad. Sci. USA, Feb. 1973; 70(2):456-458.
Ames et al., “Simple, Rapid, and Quantitative Release of Periplasmic Proteins by Chloroform,”J. Bacteriol., Dec. 1984; 160(3):1181-1183.
Atherton et al., “Phosphonopeptide Antibacterial Agents Related to Alafosfalin: Design, Synthesis, and Structure-Activity Relationships,”Antimicrob. Agents and Chemother., Dec. 1980; 18(6):897-905.
Barak et al., “Specialized Peptide Transport System inEscherichia coli,” J. Bact., Jun. 1975; 122(3):1200-1207.
Bodanszky et al., “Synthesis of Biocytin-Containing Peptides,”J. Am. Chem. Soc., Jan. 1977; 99(1):235-239.
Bonfils et al., “Uptake by Macrophages of a Biotinylated Oligo-α-deoxythymidylate by Using Mannosylated Streptavidin,”Bioconjug. Chem., Jul.-Aug. 1992; 3(4):277-284.
Campbell, “Sensitive Mutants of Bacteriophage λ,”Virology, May 1961; 14:22-32.
Campbell et al., “A Mutant ofEscherichia coliThat Requires High Concentrations of Biotin,”Proc. Nat. Acad. Sci. USA, Mar. 1972; 69(3):676-680.
Campbell et al., “Biotin Regulatory (bir) Mutations ofEscherichia coli,” J. Bacteriol., Jun. 1980; 142(3)1025-1028.
Chen et al, “Increased Cellular Uptake of the Human Immunodeficiency Virus-1 Tat Protein after Modification with Biotin,”Analytical Biochemistry, May 1995; 227:168-175.
Dargis et al., “Use of Biotinylated β-Lactams and Chemiluminescence for Study and Purification of Penicillin-Binding Proteins in Bacteria,”Antimicrobial Agents and Chemotherapy, May 1994; 38(5):973-980.
Detmers et al., “Kinetics and Specificity of Peptide Uptake by the Oligopeptide Transport System ofLactococcus lactis,” Biochemistry, Nov. 1998; 37:16671-16679.
Eisenberg et al., “Properties of α-Dehydrobiotin-Resistant Mutants ofEscherichia coliK-12,”J. Bacteriol., Apr. 1975; 122(1):66-72.
Fall et al., “Analysis of bacterial biotin-proteins,”Biochim. Biophys. Acta, Feb. 1975; 379(2):496-503.
Gilleland, Jr., et al., “Ultrastructural and Chemical Alteration of the Cell Envelope ofPseudomonas aeruginosa, Associated with Resistance to Ethylenediaminetetraacetate Re

Affiliated with

Also associated with

Rating

Biotin-facilitated transport in gram negative bacteria does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biotin-facilitated transport in gram negative bacteria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biotin-facilitated transport in gram negative bacteria will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4114954